Showing results (81-90 of 102) with videos related to
Sort By:
Pageof 11
Thyroid : Official Journal of the American Thyroid Association|February 22, 2014
Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studiesLi Xu, Matthias Port, Stefano Landi, et al.3 Biotech|January 23, 2024
Strategies for single base gene editing in an immortalized human cell line by CRISPR/Cas9 technologyAlda Corrado, Romina Aceto, Simona Miglietta, et al.Journal of Medical Genetics|July 30, 2016
New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutationsCristina Romei, Francesca Casella, Alessia Tacito, et al.Genes|September 13, 2019
Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET MutationsRossella Elisei, Alessia Tacito, Teresa Ramone, et al.European Journal of Endocrinology|June 3, 2015
Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancerRossella Elisei, Loredana Lorusso, Paolo Piaggi, et al.Thyroid : Official Journal of the American Thyroid Association|December 18, 2012
Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer seriesRaffaele Ciampi, Caterina Mian, Laura Fugazzola, et al.Clinical Endocrinology|December 3, 2014
Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?Cristina Romei, Alessia Tacito, Eleonora Molinaro, et al.The Journal of Clinical Endocrinology and Metabolism|October 16, 2012
The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort studyRossella Elisei, David Viola, Liborio Torregrossa, et al.Case Reports in Endocrinology|August 18, 2020
A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline DeletionCarlotta Giani, Teresa Ramone, Cristina Romei, et al.The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomasEfisio Puxeddu, Sonia Moretti, Rossella Elisei, et al.Pageof 11